Non-small cell lung cancer (NSCLC) patients with loss of the tumor suppressor gene STK11 are resistant to immune checkpoint therapies like anti-PD-1. Our in vivo CRISPR screen identified HDAC1 as a ta
Additional file 10: Table S2. Compounds used in the substrate screening assay by oxygen consumption using a Clark-type electrode. All substrates were purchased from Sigma Aldrich (Belgium) except Tran
